Page 522 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

27. Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in myocardial infarction. A report of the American College of
Prinzmetal angina. Documentation by coronary arteriography. Cardiology/American Heart Association Task Force on Practice
N Engl J Med. 1973;288:745-751. Guidelines (Committee on Management of Acute Myocardial
28. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-con- Infarction). J Am Coll Cardiol. 1999;34:890-911.
verting-enzyme inhibitor, ramipril, on cardiovascular events in 41. Kushner FG, Hand M, Smith SC Jr, et al. 2009 Focused
high-risk patients. N Engl J Med. 2000;342:145-153. Updates: ACC/AHA Guidelines for the Management of Patients
29. Fraker TD Jr, Fihn SD, Gibbons RJ, et al. 2007 chronic angina With ST-Elevation Myocardial Infarction (Updating the 2004
focused update of the ACC/AHA 2002 Guidelines for the man- Guideline and 2007 Focused Update) and ACC/AHA/SCAI
agement of patients with chronic stable angina: a report of the Guidelines on Percutaneous Coronary Intervention (Updating
American College of Cardiology/American Heart Association the 2005 Guideline and 2007 Focused Update): A Report of the
Task Force on Practice Guidelines Writing Group to develop American College of Cardiology Foundation/American Heart
the focused update of the 2002 Guidelines for the management Association Task Force on Practice Guidelines. Circulation.
of patients with chronic stable angina. Circulation. 2007;116: 2009;120:2271-2306.
2762-2772. 42. Go AS, Barron HV, Rundle AC, Ornato JP, Avins AL. Bundle-
30. Lipid Research Clinics Program. The lipid research clinics branch block and in-hospital mortality in acute myocar-
coronary primary prevention trial results. II. The relationship of dial infarction. National Registry of Myocardial Infarction 2
reduction in incidence of coronary heart disease to cholesterol Investigators. Ann Intern Med. 1998;129:690-697.
lowering. JAMA. 1984;251:365-374. 43. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto
31. Frick MH, Elo O, Haapa K, et al. Helsinki heart study: Miocardico (GISSI). Effectiveness of intravenous thrombo-
primary-prevention trial with gemfibrozil in middle-aged men lytic treatment in acute myocardial infarction. Lancet. 1986;1:
with dyslipidemia. Safety of treatment, changes in risk fac- 397-402.
tors, and incidence of coronary heart disease. N Engl J Med. 44. TIMI Study Group. The Thrombolysis in Myocardial Infarction
1987;317:1237-1245. (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:
32. Heart Protection Study Collaborative Group. MRC/BHF Heart 932-936.
Protection Study of cholesterol lowering with simvastatin in 45. TIMI Investigators. Effects of tissue plasminogen activator and
20,536 high-risk individuals: a randomised placebo-controlled a comparison of early invasive and conservative strategies in
trial. Lancet. 2002;360:7-22. unstable angina and non-Q-wave myocardial infarction. Results
33. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to of the TIMI IIIB Trial. Circulation. 1994;89:1545-1556.
prevent vascular events in men and women with elevated 46. GUSTO Investigators. An international randomized trial com-
C-reactive protein. N Engl J Med. 2008;359:2195-2207. paring four thrombolytic strategies for acute myocardial infarc-
34. Scandinavian Simvastatin Survival Study Group. Randomised tion. N Engl J Med. 1993;329:673-682.
trial of cholesterol lowering in 4444 patients with coronary 47. GUSTO Angiographic Investigators. The effects of tissue plas-
heart disease: the Scandinavian Simvastatin Survival Study (4S). minogen activator, streptokinase, or both on coronary-artery
Lancet. 1994;344:1383-1389. patency, ventricular function, and survival after acute myocar-
35. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin dial infarction. N Engl J Med. 1993;329:1615-1622.
on coronary events after myocardial infarction in patients with 48. Global Use of Strategies to Open Occluded Coronary Arteries
average cholesterol levels. N Engl J Med. 1996;335:1001-1009. (GUSTO III) Investigators. A comparison of reteplase with
36. Long-Term Intervention with Pravastatin in Ischaemic Disease alteplase for acute myocardial infarction. N Engl J Med.
(LIPID) Study Group. Prevention of cardiovascular events and 1997;337:1118-1123.
death with pravastatin in patients with coronary heart disease 49. Assessment of the Safety and Efficacy of a New Thrombolytic
and a broad range of initial cholesterol levels. N Engl J Med. Investigators. Single-bolus tenecteplase compared with front-
1998;339:1349-1357. loaded alteplase in acute myocardial infarction: the ASSENT-2
37. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guide- double-blind randomised trial. Lancet. 1999;354:716-722.
line update for the management of patients with chronic stable 50. Grines CL, Browne KF, Marco J, et al. A comparison of immedi-
angina—summary article: a report of the American College of ate angioplasty with thrombolytic therapy for acute myocardial
Cardiology/American Heart Association Task Force on Practice infarction. The Primary Angioplasty in Myocardial Infarction
Guidelines (Committee on the Management of Patients With Study Group. N Engl J Med. 1993;328:673-679.
Chronic Stable Angina). Circulation. 2003;107:149-158. 51. GUSTO IIb Investigators. A comparison of recombinant hiru-
38. Ferguson JJ III, Cohen M, Freedman RJ Jr, et al. The cur- din with heparin for the treatment of acute coronary syn-
rent practice of intra-aortic balloon counterpulsation: results dromes. N Engl J Med. 1996;335:775-782.
from the Benchmark Registry. J Am Coll Cardiol. 2001;38: 52. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ.
1456-1462. Primary coronary angioplasty compared with intravenous
39. Gewirtz H, Ohley W, Williams DO, Sun Y, Most AS. Effect of thrombolytic therapy for acute myocardial infarction: six-
intraaortic balloon counterpulsation on regional myocardial month follow up and analysis of individual patient data from
blood flow and oxygen consumption in the presence of coro- randomized trials. Am Heart J. 2003;145:47-457.
nary artery stenosis: observations in an awake animal model. 53. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus
Am J Cardiol. 1982;50:829-837. intravenous thrombolytic therapy for acute myocardial infarc-
40. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/ tion: a quantitative review of 23 randomised trials. Lancet.
AHA guidelines for the management of patients with acute 2003;361:13-20.

Section03-O-ref.indd 2 1/20/2015 7:10:23 AM